Introduction
It is now generally accepted that three distinct muscarinic receptor subtypes can be distinguished by pharmacological mcans {Eglen and Whiting, 1986; Mitchelson, 1988; Levine and Birdsall, 1989; Lazarcno et al., 1990; Lambrecht et al., 1989; Waelbroeck et al., 1989 . These three subtypes, termed M 1 , M 2 and M 3 receptors, have also becn shown to correspond to the structurally distinct cloned muscarinic receptors ml, m2 and m3, respectively (Akiba et al., 1988; Bon- Correspondencc to: G. Lambrecht, Department of Pharmacology, University <>f Frankfurt, Theodor-Stern·Kai 7, Geb. 75A, D-6000 Frankfurt/Main, Germany. Tel. 49.69.6301 6077, fax 49.69.6301 6475. ner et al., 1987; Buckley et al., 1989; Dörje et al., 1991b) . M 1 receptors appcar tobe locatcd primarily on neuronal tissue, M 2 reccptors have been most often localized in cardiac tissue, smooth muscle and lower brain areas and M 3 rcceptors are found predominantly in exocrinc glands and smooth muscle {Eglen and Whiting, 1986; Mitchelson, 1988; Lambrecht et al., 1989; Waelbroeck et al., 1990; Dörje et al., 1991a) . There is a candidate M 4 receptor, found in rat striatum (Waelbroeck et al., 1 990) . rabbit Jung (Lazareno et al., 1990 ) and NG108-l5 cells (Michel et al., 1989; Caulfield and Brown, 1991) , which is considered to be the m4 gene product (Dörje et al., 199la; Brann et al., 1988) .
Each of the three subtypes, M 1 , M 2 and M 3 , can be identified in vascular prcparations depending on thc species, tissue and function examincd. In general, M 3 receptors mediate EDRF-depcndent relaxation, M 1 reccptors mediate venous contraction and M 2 or M .~ rcceptors appear to inhibit noradrcnaline overflow (Fernandcs et al., 1991 ; for a rcview, see Eglcn and Whiting, 1990) . Reccntly, M _, receptors havc been implicated in endothclial-dependent vascular relaxation in the rabbit car artery and in bovine coronary artery, mediating both endothelial-depcndent rclaxation as wcll as endothelial-indepcndent vascular contraction (Duckles and Garcia-Villalon, 1990; Brunn er et al., 199la,b) .
Muscarinic receptors, whose activation produces vasodilation, havc also becn demonstratcd in resistancc vcssels of the gastrointestinal microcirculation, thc submucosal arterioles of guinea-pig ileum (Neild ct al., 1990) . These submucosal artcriolcs arc inncrvatcd by cholinergic enteric neurones and thesc ncuroncs rcleasc acctylcholinc to produce pronounccd vasodilation. This vasodilation is presumably causcd by activation of M 3 rcceptors prescnt on thesc blood vessels although it is not yet known whcther muscarinic rcceptors reside on vascular smooth muscle directly or on thc vascular endothelium (Neild et al., 1990) .
The present expcrimcnts werc undcrtaken to provide a dctailed pharmacological characterization of the muscarinic rcceptor subtype which mediates thc cholinergic vasodilation in submucosal arterioles of guinca-pig ileum. The in vitro submucosal artcriolar preparation uscd (Neild ct al., 1990) allows the study of rcceptor-mediated vasodilation by means of a computcr-assisted vidcomicroscopy system without the need to isolate individual segmcnts of thc vascular trec.
Materials and methods
Thc pharmacological experiments were pcrformed at two different institutcs [Portland (U.S.A.) and Frankfurt (F.R.G.)] using nearly identical hardware. For tcchnical rcasons thc experimental design used in Portland differed slightly from that in Frankfurt (see table 1 ). The data obtained in Portland are marked as 'method P' whereas those from Frankfurt are listed undcr 'method F'.
I. Tissue preparation
Submucosal plexus preparations were obtained from the small intestine of guinea-pigs that had been killed by a blow on the head and exsanguinated. Preparations were dissected as described previously (Neild et al., 1990) . Briefly, the mucosa was stripped from segments (8-12 mm long, 5-7 mm wide) of the small intestine and thc submucosal plexus was pulled away from the underlying circular smooth muscle. Thc plcxus was Muscarinic agonist:
M uscarinc 1 carhachol Methacholinc pinncd onto transparent silicone rubber, mucosal surface down, in the base of a small organ bath (0.3-0.5 ml volumc). The prcparation consistcd of arteriolar trecs, thc outside diamcters of which ranged from 50-75 p.m; tcnsion applied to the connective tissue sheath rcsulted in approximately optimum-lcngth conditions in the vascular nctwork (Vanner et al., 1990) . Physiological saline solution or Tyrode solution (for composition see table 1 ), gassed with 95% 0 2 -5% C0 2 , flowed continuously at 32-36°C at 8-10 mljmin. Preparations were cquilibrated for 45-60 min prior to initiation of pharmacological experiments.
Monitaring of arteriolar diameter
The outside diameter of submucosal arterioles was monitorcd with the Diamtrak :~ system as dcscribcd previously (Neild, 1989; Neild et al., 1990) . This system uscs an lmaging Tcchnology PCVisionPius framegrabber board (Woburn, MA, U.S.A.) in an AT-compatible computer to digitize television images of outside edges of the arteriole and converts this result to an analog signal which is displayed on a conventional strip chart recordcr. Resolution of the systcm was < 1 ~m; the sampling rate was 10-20 Hz.
Agonist potencies
To preconstrict the vessel, method P used the thromboxane receptor agonist U-46619 at a concentration of 285-300 nM, whereas in method F (-)-noradrenalinc (10 p.M) was used. 8oth agonists produced 80-90% of the maximum contractile rcsponse. The noradrenalinc Solution was freshly prepared beforc each expcriment. No other precautions were taken to prevent oxidation of the catecholamine because of thc high concentration used and the short duration of each experiment (Neild and Kotecha, 1989) . All muscarinic agonists werc applied to prcconstricted vcssels by superfusion for 2-4 min (per agonist concentration) with a 20-min washaut period between applications. In initial experiments, all agonists were applied in a noncumulative fashion with 4-6 concentrations of agonist applied to each vcsscl. In later experiments agonists wcre applied cumulatively because no significant differcnccs werc found bctween concentration-response curves obtained by either of these methods. The apparent potcncy of a muscarinic agonist is expressed as its EC 511 value, i.c. the molar concentration inducing 50% of the individual maximal vasodilation.
Antagonist affinities
Affinitics for muscarinic antagonists werc obtained by constructing concentration-response curves for agonists in the absence and then presencc of two to four increasing conccntrations of the antagonist. All antagonists wcre present for 12-15 min prior to agonist application. EC 511 values were used to construct Schild plots, and slopes were obtained by Ieast-squares fit. When slopes were not significantly different from unity, thc x-intercept (pA 2 value) was obtained by fitting the best linc with unit slope (Tallarida and Murray, 1986) .
Data analysis
The data are presented as means ± S.E.M. Diffcrences between mcan values were tcsted for statistical significance by using Student's t-test; P < 0.05 was accepted as being significant.
Drugs
The following drugs were used: acetylcholine chloridc, carbachol chloride, eserine hemisulfate, hexamethonium bromide, ( ± )-muscarine chloride, oxotremorine sesquifumarate, sodium nitroprusside and tetrodotoxin (all from Sigma, St. Louis, U.S.A.); (-)-noradrenaline hydrochloride (Fiuka. Buchs, Switzerland); 9, 11-dideoxy-11 a ,9a-epoxy-methano-pros- Figure 1 shows typical vasodilations produccd by muscarinic agonists applied in a cumulativc fashion to guinea-pig ileum submucosal arteriolar preparations. Maximum dilations produced by muscarine ( fig. 1A) werc 84 ± R% (n = 43) and by methacholine 88 ± 6% (n = 4H) of the resting (non-constrictcd) outside diamcter and this maximum response was not significantly different from the vasodilation produced by a supramaximal concentration of sodium nitroprusside (20 J.LM; vasodilation = 79 ± 6%, n = 14). All agonist effects were considercd to bc due to direct activation of muscarinic receptors on thc submucosal arterioles, and not to possiblc indirect activation of submucosal cholinergic neurones innervating the blood vessel, because responscs were not altered in the presence of hexamcthonium (100 J.LM, n = 8) or tetrodotoxin (0.5-1 J.LM, n = 12).
Results

/. Agonbits
Acetylcholine, muscarine, methacholine, carbachol, APE, oxotremorine and 4-CI-McN-A-343 dilated submucosal arterioles to the same maximum ( fig. 2 ; data not shown for methacholine); EC 50 valucs are shown in tablc 2. The acetylcholine-induccd vasodilation was significantly enhanced in the presence of the cholinesterasc inhibitor eserine ( 1 J.L M), which produced an approximatcly two-fold shift to the left in the concentration-vasodilation curve ( fig. 2A ). Higher concentrations of cserine (10 and 100 J.LM) had no further effect (n = 5). Vasodilations produced by the agonists werc maintained for the duration of agonist application and were reproducible in the same arteriolc for up to 5 h during rcpeated applications at intervals of 20 min. McN-A-343 and NEN-APE were virtually ineffective in producing arteriolar vasodilation; concentrations as high as 100 J.L M produced less than 10% of the vasodilation evoked by application of the other agonists (figs. lC and 2). Neild et al. (1990) . h Data from Lambrecht et al. (1989) . c Data from Eberlein et al. (1989) . d Data from Feitelet al. (1990) . e Only two concentrations of (S)-HHD were investigated due to non-speciric effects of the antagonist at higher concentrations. The pA 2 value was therefore dctermined from the individual dosc ratios according to Tallarida et al. (1979) . r Data from Dörje ct al. ( 1990) . 
2. Antagonists
The antagonists investigated all shifted the agonist concentration-vasodilation curves parallel to higher concentrations without any appreciable changes of pre- e., e.
Cl B'1
ci: constriction or reduction of thc maximum response. This is illustrated for p-F-HHSiD and (R)-HHD in fig.  3 . The effects of 4-DAMP, (R)-HHD and p-F-HHSiD were readily reversible within 20-30 min of washout even at the highcst concentrations used, while those of (S)-HHD were slowly and, at the higher conccntrations, only partially reversible (method P). Arunlakshana-Schild plots werc linear and slopes were not significantly different from unity, except in thc case of p-F-HHSiD (method F: slope = 0.7) and (S)-HHD (method P; using 10, 30, 100 and 300 1-'M to construct the Schild plot). However, when the highest antagonist concentration (300 ~J.M) was omitted from the analysis, the slope was not significantly different from unity (table 3) . Therefore, it was assumed that this very high concentration of (S)-HHD produccd additional, nonspecific effects on submucosal arterioles. With mcthod F is was not possible to construct Schild plots for (S)-HHD bccause of similar nonspecific effects aceurring at concentrations higher than 10 J.L M, which led to unstable declining preconstrictions. Thus, only two concentrations (3 and 10 1-' M) were investigated and the pA 2 value was therefore detcrmined from the individual dose ratios (Tallarida et al., 1979) . The (R)-enantiomer of HHD displayed 250-to 500-fold higher affinity than its corresponding (S)-isomer. Schild plots for 4-DAMP, (R)-HHD, (S)-HHD and p-F-HHSiD are shown in fig. 4 (method P). Table 3 summarizes antagonist pA 2 values obtained from all experiments.
Discussion
Based on pA 2 values obtained with pirenzepine,
5, 11-dihydro-6H-pyrido(2,3-bX 1 ,4)-benzodiazcpin-6-one (AF-DX 116) and hexahydro-sila-difcnidol (HHSiD) (table 3; Neild et al., 1990) , wc had previously suggested that submucosal artcrioles of the guinea-pig ileum possess the functional M ~ muscarinic reccptor which mediates vasodilation. This study was dcsigncd to characterizc this muscarinic receptor further, using agonists and a larger nurober of subtype selective antagonists including one pair of enantiomcrs. The experiments werc carried out at two institutes; the most important differences betwcen thc methods used in Portland and Frankfurt (method P and F) wcrc thc use of (-)-noradrenaline instcad of U-46619 to preconstrict the vessels and methacholine instcad of muscarine or carbachol as muscarinic agonist for antagonist invcstigations. Furthermore there were minor diffcrenccs in the concentration of Ca 2 + and K + in thc buffcrs ( 1.8 vs. 2.5 mM, 2.68 vs. 5 mM, rcspectivcly; table I). However, both mcthods produccd the same agonist potencics and antagonist affinitics (tables 2 and 3).
Thc results from the prcsent study provide convincing evidencc that a singlc type of muscarinic reccptor. the M 1 subtypc, mediates thc cholinergic vasodilation in these submucosal arterioles.
The agonists uscd in the present experiments, with the cxception of McN-A-343 and NEN-APE, acted as (table 2) , the functional muscarinic rcccptor of which has bcen characterized as the M~ subtype. McN-A-343 was ineffective in producing vasodilation in submucosal arterioles. This is consistent with its incffectiveness in producing endothelial-dependent relaxation in rabbit ear artcry or cndothelial-independent contraction in bovine coronary artcry (Duckles, 19B8) . McN-A-343 has hecn proposcd to act as a sclcctivc M 1 agonist (JokischMehrling et al., 1989) hut exhibitsvariable responscs at all muscarinic rcceptor subtypes, depending upon thc rcceptor rescrve of the preparation (Eglen and Whiting, 1986) . Thc M 2 and M 3 activity rcported varics from no agonistic action (Eglen ct al., 1987) defcrens: pD 2 = 6.3, i.a. = 1.1 or rat left atrium: pD 2 = 6.6, i.a. = 0.8). At M 1 (rabbit vas deferens) and M 3 (rat ileum) rcceptors it behaves as a competitive antagonist (pA 2 = 5.8 and pA 2 = 6.1, respectively) (Eltze et al., 199 1) . These findings might explain its Iack of agonistic activity at muscarinic reccptors in submucosal arterioles. All antagonists investigated acted as pure competitive antagonists of the methacholine-, muscarinc· or carbachol-induced vasodilation. Morcover, since the slopes of Arunlakshana-Schild regression lines did not significantly differ from unity (with cxception of p-FHHSiD, mcthod F), the prcsencc of a mixture of functional subtypes appears to bc unlikcly. Tablc 3 shows that there is a remarkable agrcemcnt in pA 2 valucs for the antagonists studied in submucosal artcrioles and in guinea-pig ileum longitudinal smooth muscle preparations. lt is also worth noting that these valucs arc very similar to those obtained for the cloned m3 muscarinic receptor (Dörje ct al., 1991 b; Buckley ct al., 1989; Wesset al.. 1990 . Figure 5 shows a comparison of the pA 2 values determincd at submucosal artcrioles and thc corresponding binding affinities (pK i values) obtained in radioligand binding assays at M 1 , M 2 , M 3 and M 4 reccptors (data from Waelbroeck et al., 1990, I99la,b, and personal communication) . For receptor identity, the data points should not significantly deviate from the theoretical equality line (y = x).
The distance to this linc (given in fig. 5 as antilog of thc difference between pA 2 and pK 1 values) is a direct measure of receptor selectivity. The affinity of pirenzepine (pA 2 = 6.74) for the muscarinic receptor in submucosal arterioles was 40-fold lower than that observed at M 1 (human NB-OKl cells) receptors, thercby cxcluding the presence of functional M 1 receptors. The evident discrimination for AQ-RA 741 (63-fold lowcr than observed at M 2 and 40-fold lower than dctermined at M 4 receptors), AF-DX 3H4 and HHSiD (63-fold highcr than observed at M 2 receptors) furthcrmore clearly excludes M 2 or M 4 receptors from mediating the vasodilation. A highly significant correlation was found for the M 3 (rat pancreas) preparation only. Calculation of the eudismic index for the two enantiomers of HHD (method P: 2.44, method F: 2.36) and comparison of thesc values with data obtained in the same radioligand assay (M 1 : 2.2, M 2 : 1.2, M 3 : 2.2, M 4 : 2.0) also exclude the M 2 subtype and favour the M ·' subtype for mediating the vasodilation. Thus, it can be concluded that the functional muscarinic receptor mediating vasodilation in guinea-pig ileum submucosal arterioles is of the M 3 subtype.
Dcpending on spccies, tissue and function measured, each of the three subtypes, M 1 , M 2 and M :\• have bcen identified on vascular smooth muscle. In general, M 1 receptors mediate venous contraction, M 2 or M 3 receptors appear to inhibit noradrenaline over-59 flow and direct EDRF-dcpendent relaxations are mediated in the majority of preparations by M ·' receptors (Fcrnandes et al., 1991 ; for a review, see Eglen and Whiting, 1990) . Recent studies report M ~ receptormediated relaxation of the feline middlc cerebral artery (Dauphin and Harnet, 1990 ) and of bovine coronary artcry (Brunner et al., 1991a) . In addition, a study of muscarinic rclaxation in the rabbit ear artcry has shown pA 2 values for pirenzepinc (6.8), AF-DX I 16 (6.0) and HHSiD (8.2) (Duckles and Garcia-Villalon, 1990 ) similar to those determined in submucosal artcriolcs (this study). Therefore our results ohtained with muscarinic agonists and antagonists are in good agrecment with thcse carlicr findings.
In conclusion, the present study investigated the muscarinic reccptors of resistance vessels in guinea-pig ileum by the use of computer-assisted videomicroscopy. The muscarinic reccptor which mediates vasodilation of the precontracted submucosal arterioles was characterized by determining the potcncies of a scries of muscarinic agonists and the affinities of various selcctive muscarinic antagonists. The results providc convincing evidence that a single type of muscarinic receptor, the M 3 subtype, mediates thc cholinergic vasodilation in submucosal artcrioles of thc guinea-pig ileum. Thus. thc application of computer-assisted videomicroscopy for tracking thc diameter of small rcsistance vesscls (i.e. arterioles) is a useful new method for pharmacological investigations of drug actions at muscarinic receptors in thc periphcral vascular system.
